Search

Pulse Biosciences Inc

Closed

SectorHealthcare

52.26 -5.99

Overview

Share price change

24h

Current

Min

53.5

Max

56.22

Key metrics

By Trading Economics

Income

-6.1M

-25M

Sales

33K

434K

EPS

-0.36

Profit margin

-5,681.336

Employees

116

EBITDA

-5.5M

-24M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+16.14% upside

Dividends

By Acuity

Next Earnings

5 lis 2026

Market Stats

By TradingEconomics

Market Cap

1.1B

3.8B

Previous open

58.25

Previous close

52.26

Pulse Biosciences Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

29 paź 2026, 20:21 UTC

Pulse Biosciences Inc is trading higher in after-market hours, rising from a low shortly after the market closed and significantly above its 20-day moving average.

27 paź 2026, 19:46 UTC

Pulse Biosciences Inc shares fell, retracing from earlier highs to just below Monday's close, while remaining above its 20-day moving average.

26 paź 2026, 23:46 UTC

Pulse Biosciences Inc saw modest gains in after-market hours, trading higher and remaining above its 20-day moving average and near the upper end of its one-month range.

23 paź 2026, 20:07 UTC

Pulse Biosciences Inc shares are advancing, continuing an upward trend since Thursday, despite earlier pulling back from a session high.

22 paź 2026, 20:07 UTC

Pulse Biosciences Inc shares advanced, reflecting a broader upward trend in the market, which has seen a cumulative return of 2.87% since Wednesday's close.

21 paź 2026, 20:07 UTC

Pulse Biosciences Inc is trading modestly higher, aligning with significant overall market gains, and remains above its 20-day moving average.

20 paź 2026, 22:11 UTC

Pulse Biosciences Inc shares declined in after-market trading, following a notable drop at Tuesday's close amid weakness in the Health Care Equipment sub-sector.

16 paź 2026, 20:07 UTC

Pulse Biosciences Inc shares declined significantly, finishing well below their 20-day moving average after a downward trend that began Thursday.

15 paź 2026, 20:07 UTC

Pulse Biosciences Inc shares fell sharply, marking the fifth consecutive session of declines, closing significantly below its 20-day moving average.

14 paź 2026, 21:51 UTC

Pulse Biosciences Inc is trading lower in after-market hours, continuing a trend of three consecutive lower closes amid broader market declines following rising inflation.

13 paź 2026, 20:01 UTC

Social Media

Oppenheimer raises its price target on Pulse Biosciences Inc to 60 from 35 while maintaining an Outperform rating after a non-deal roadshow.

12 paź 2026, 20:06 UTC

Pulse Biosciences Inc shares are declining, continuing a downward trend since Friday.

9 paź 2026, 22:20 UTC

Pulse Biosciences Inc shares are declining in after-market trading, hitting their lowest point since Friday's close after a brief opening gain.

7 paź 2026, 20:07 UTC

Event

Shares of Pulse Biosciences Inc are declining despite the successful enrollment of 164 patients in its NANOPULSE-AF Study, remaining below its 20-day moving average.

5 paź 2026, 20:06 UTC

Pulse Biosciences Inc is advancing, continuing its upward trend since Friday, despite an earlier pullback from a session high. The health care equipment sector shows notable gains.

2 paź 2026, 20:07 UTC

Pulse Biosciences Inc shares fell sharply, closing at their lowest point amid broader market weakness and trading below the 20-day moving average.

1 paź 2026, 20:07 UTC

Pulse Biosciences Inc shares fell sharply, pulling back from a morning peak and remaining below its 20-day moving average.

30 wrz 2026, 21:01 UTC

Pulse Biosciences Inc closed lower in after-market trading, marking its fourth consecutive session of decline and remaining significantly below its 20-day moving average.

29 wrz 2026, 21:21 UTC

Pulse Biosciences Inc has declined in after-market trading, moving lower since Tuesday's close and falling below its 20-day moving average.

28 wrz 2026, 22:21 UTC

Pulse Biosciences Inc saw a significant increase in after-market trading, reaching a notable peak and remaining well above its 20-day moving average.

25 wrz 2026, 20:07 UTC

Pulse Biosciences Inc shares fell modestly as the broader market declined, continuing a trend of five consecutive sessions finishing lower.

24 wrz 2026, 20:07 UTC

Pulse Biosciences Inc. shares fell sharply, continuing a trend of declines over the last four sessions after an earlier gain in the current session.

23 wrz 2026, 19:25 UTC

Pulse Biosciences Inc shares fell modestly, continuing a downward trend observed over the past three sessions, despite initially rising sharply after the market opened.

22 wrz 2026, 19:34 UTC

Pulse Biosciences Inc shares fell sharply, declining from Monday's close despite remaining above the 20-day moving average and within the one-month range.

21 wrz 2026, 20:12 UTC

Pulse Biosciences Inc declined in after-market trading following Monday's close, remaining flat throughout the session but positioned above its 20-day moving average.

18 wrz 2026, 20:02 UTC

Pulse Biosciences Inc shares are rising sharply, reaching a notable high and trading above its 20-day moving average with unusually high volume.

17 wrz 2026, 20:07 UTC

Pulse Biosciences Inc is gaining, reflecting positive movement in the health care equipment sector, despite pulling back from an earlier session high.

16 wrz 2026, 23:36 UTC

Pulse Biosciences Inc is declining in after-market trading, remaining significantly below its 20-day moving average and near the lower end of its one-month range.

15 wrz 2026, 22:02 UTC

News
Event

Pulse Biosciences has an $85 million equity distribution agreement with Mizuho. Shares are trading lower in after-market hours following the announcement.

14 wrz 2026, 20:08 UTC

Pulse Biosciences Inc shares are higher today, maintaining a strong position since Friday's close and peaking significantly above the 20-day moving average.

Peer Comparison

Price change

Pulse Biosciences Inc Forecast

Price Target

By TipRanks

16.14% upside

12 Months Forecast

Average 62.333 USD  16.14%

High 73 USD

Low 55 USD

Based on 6 Wall Street analysts offering 12 month price targets forPulse Biosciences Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

6 ratings

6

Buy

0

Hold

0

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
help-icon Live chat